Difference between revisions of "Template:Adrenergic receptor modulators"
Jump to navigation
Jump to search
blackwiki>Anypodetos m (Simplify markup, replaced: • → • (602), <br> → <br /> using AWB) |
|||
| Line 13: | Line 13: | ||
| group2 = [[α2-adrenergic receptor|α<sub>2</sub>]] | | group2 = [[α2-adrenergic receptor|α<sub>2</sub>]] | ||
| − | | list2 = '''Agonists''': [[(R)-3-Nitrobiphenyline]] • [[4-NEMD]] • [[6-Fluoronorepinephrine|6-FNE]] • [[Amitraz]] • [[Apraclonidine]] • [[Brimonidine]] • [[Clonidine]] • [[Detomidine]] • [[Dexmedetomidine]] • [[Dihydroergotamine]] • [[Dipivefrine]] • [[Dopamine]] • [[Ephedrine]] • [[Ergotamine]] • [[Epinephrine]] (Adrenaline) • [[Esproquin]] • [[Etilefrine]] • [[Ethylnorepinephrine]] • [[Guanabenz]] • [[Guanfacine]] • [[Guanoxabenz]] • [[Levonordefrin]] • [[Lofexidine]] • [[Medetomidine]] • [[Methyldopa]] • [[Mivazerol]] • [[Naphazoline]] • [[Norepinephrine]] (Noradrenaline) • [[Phenylpropanolamine]] • [[Piperoxan]] • [[Pseudoephedrine]] • [[Rilmenidine]] • [[Romifidine]] • [[Talipexole]] • [[Tetrahydrozoline]] • [[Tizanidine]] • [[Tolonidine]] • [[Urapidil]] • [[Xylazine]] • [[Xylometazoline]]<br/>'''Antagonists''': [[Pyrimidinylpiperazine|1-PP]] • [[Adimolol]] • [[Aptazapine]] • [[Atipamezole]] • [[BRL-44408]] • [[Buflomedil]] • [[Cirazoline]] • [[Efaroxan]] • [[Esmirtazapine]] • [[Fenmetozole]] • [[Fluparoxan]] • [[GYKI-12,743]] • [[GYKI-16,084]] • [[Idazoxan]] • [[Mianserin]] • [[Mirtazapine]] • [[MK-912]] • [[NAN-190]] • [[Olanzapine]] • [[Phentolamine]] • [[Phenoxybenzamine]] • [[Piperoxan]] • [[Piribedil]] • [[Rauwolscine]] • [[Rotigotine]] • [[SB-269,970]] • [[Setiptiline]] • [[Spiroxatrine]] • [[Sunepitron]] • [[Tolazoline]] • [[Yohimbine]]<br/><small>* Note that many [[atypical antipsychotic]]s and [[azapirone]]s like [[buspirone]] and [[gepirone]] (via metabolite [[Pyrimidinylpiperazine|1-PP]]) antagonize α<sub>2</sub>-adrenergic receptors as well.</small> | + | | list2 = '''Agonists''': [[(R)-3-Nitrobiphenyline]] • [[4-NEMD]] • [[6-Fluoronorepinephrine|6-FNE]] • [[Amitraz]] • [[Apraclonidine]] • [[Brimonidine]] • [[Cannabivarin]] • [[Clonidine]] • [[Detomidine]] • [[Dexmedetomidine]] • [[Dihydroergotamine]] • [[Dipivefrine]] • [[Dopamine]] • [[Ephedrine]] • [[Ergotamine]] • [[Epinephrine]] (Adrenaline) • [[Esproquin]] • [[Etilefrine]] • [[Ethylnorepinephrine]] • [[Guanabenz]] • [[Guanfacine]] • [[Guanoxabenz]] • [[Levonordefrin]] • [[Lofexidine]] • [[Medetomidine]] • [[Methyldopa]] • [[Mivazerol]] • [[Naphazoline]] • [[Norepinephrine]] (Noradrenaline) • [[Phenylpropanolamine]] • [[Piperoxan]] • [[Pseudoephedrine]] • [[Rilmenidine]] • [[Romifidine]] • [[Talipexole]] • [[Tetrahydrozoline]] • [[Tizanidine]] • [[Tolonidine]] • [[Urapidil]] • [[Xylazine]] • [[Xylometazoline]]<br/>'''Antagonists''': [[Pyrimidinylpiperazine|1-PP]] • [[Adimolol]] • [[Aptazapine]] • [[Atipamezole]] • [[BRL-44408]] • [[Buflomedil]] • [[Cirazoline]] • [[Efaroxan]] • [[Esmirtazapine]] • [[Fenmetozole]] • [[Fluparoxan]] • [[GYKI-12,743]] • [[GYKI-16,084]] • [[Idazoxan]] • [[Mianserin]] • [[Mirtazapine]] • [[MK-912]] • [[NAN-190]] • [[Olanzapine]] • [[Phentolamine]] • [[Phenoxybenzamine]] • [[Piperoxan]] • [[Piribedil]] • [[Rauwolscine]] • [[Rotigotine]] • [[SB-269,970]] • [[Setiptiline]] • [[Spiroxatrine]] • [[Sunepitron]] • [[Tolazoline]] • [[Yohimbine]]<br/><small>* Note that many [[atypical antipsychotic]]s and [[azapirone]]s like [[buspirone]] and [[gepirone]] (via metabolite [[Pyrimidinylpiperazine|1-PP]]) antagonize α<sub>2</sub>-adrenergic receptors as well.</small> |
| group3 = [[β-adrenergic receptor|β]] | | group3 = [[β-adrenergic receptor|β]] | ||